Today's Veterinary Business

AUG-SEP 2017

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link: https://todaysveterinarybusiness.epubxp.com/i/856474

Contents of this Issue

Navigation

Page 36 of 71

SMALL DOGS ROCK! Features Functions Benefits Subcutaneous and intravenous administration of METACAM (meloxicam) Solution for Injection An initial injection at your clinic can provide a rapid and visible onset of pain relief via subcutaneous or intravenous administration Shows owners the benefits firsthand, which helps increase compliance Liquid formulation of METACAM (meloxicam oral suspension) Can be dosed in 1-lb and 5-lb increments Allows for precise dosing for any-sized dog Titration of METACAM (meloxicam oral suspension) to lowest effective dose Follows the recommendations set forth by the FDA 1 Extends the duration of the bottle to increase convenience and decrease cost METACAM CELEBRATES METACAM helps you administer just the right dose for each dog's individual needs. METACAM keeps them moving by managing canine osteoarthritis pain with precision dosing that's just right for them. (And, of course, it's perfect for big dogs, too.) (meloxica m ) IMPORTANT SAFETY INFORMATION for METACAM (meloxicam oral suspension) and METACAM (meloxicam) Solution for Injection: METACAM (meloxicam oral suspension) is for use in dogs only. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. As a class, cyclo- oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/ diarrhea. These are usually mild, but may be serious. If side effects occur, dog owners should halt therapy and contact their veterinarian. Dogs should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely. Please refer to the package insert for complete product information or visit www. metacam. com. Please see Brief Summary on page 34.

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Business - AUG-SEP 2017